[Form 4] Monster Beverage Corp Insider Trading Activity

Rhea-AI Filing Summary

Monster Beverage (MNST) officer, President of EMEA & OSP, reported multiple equity transactions. On 11/13/2025, the insider exercised several employee stock options at exercise prices of $25.75, $44.47, $36.62 and $50.82, acquiring blocks of common stock including 9,000, 16,100 and 13,332 shares.

On the same date, the insider sold 38,438 Monster Beverage shares at a weighted average price of $71.33, and held 21,993 common shares directly after these transactions. The filing also lists remaining stock options and restricted stock units with vesting schedules extending through March 2029 under the company’s 2020 Omnibus Incentive Plan.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Carling Guy

(Last) (First) (Middle)

1 MONSTER WAY

(Street)

CORONA CA 92879

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Monster Beverage Corp [ MNST ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	President of EMEA & OSP

3. Date of Earliest Transaction (Month/Day/Year)
11/13/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	11/13/2025		M		6	A	$25.75	21,999	D
Common Stock	11/13/2025		M		9,000	A	$44.47	30,999	D
Common Stock	11/13/2025		M		16,100	A	$36.62	47,099	D
Common Stock	11/13/2025		M		13,332	A	$50.82	60,431	D
Common Stock	11/13/2025		S		38,438	D	$71.33(1)	21,993	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Employee Stock Option (right to buy)	$25.75	11/13/2025		M			6	(2)	06/01/2028	Common Stock	6	$0	0	D
Employee Stock Option (right to buy)	$44.47	11/13/2025		M			9,000	(3)	03/12/2031	Common Stock	9,000	$0	6,000	D
Employee Stock Option (right to buy)	$36.62	11/13/2025		M			16,100	(4)	03/14/2032	Common Stock	16,100	$0	25,300	D
Employee Stock Option (right to buy)	$50.82							(5)	03/14/2033	Common Stock	(6)		20,000	D
Employee Stock Option (right to buy)	$50.82	11/13/2025		M			13,332	(7)	03/14/2033	Common Stock	13,332	$0	6,668	D
Employee Stock Option (right to buy)	$60.3							(8)	03/14/2034	Common Stock	(6)		18,000	D
Employee Stock Option (right to buy)	$55.09							(9)	03/14/2035	Common Stock	(6)		21,000	D
Restricted Stock Units	(10)							(11)	(12)	Common Stock	(6)		1,680	D
Restricted Stock Units	(10)							(13)	(12)	Common Stock	(6)		7,480	D
Restricted Stock Units	(10)							(14)	(12)	Common Stock	(6)		5,100	D
Restricted Stock Units	(10)							(15)	(12)	Common Stock	(6)		5,400	D
Restricted Stock Units	(10)							(16)	(12)	Common Stock	(6)		7,000	D

Explanation of Responses:

1. This transaction was executed in multiple trades at prices ranging from $70.09 to $71.70. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

2. The options are currently vested.

3. The options are currently vested with respect to 9,000 shares. The remaining options vest on March 12, 2026.

4. The options are currently vested with respect to 16,100 shares. The remaining options vest in two installments as follows: 11,500 shares on March 14, 2026 and 13,800 shares on March 14, 2027.

5. The options are currently vested with respect to 5,000 shares. The remaining options vest in three installments as follows: 4,000 shares on March 14, 2026; 5,000 shares on March 14, 2027 and 6,000 shares on March 14, 2028.

6. No transaction is being reported at this time. This line is only reporting holdings as of the date hereof.

7. The options are currently vested with respect to 13,332 shares. The remaining options vest on March 14, 2026.

8. The options are currently vested with respect to 1,800 shares. The remaining options vest in four installments as follows: 2,700 shares on March 14, 2026; 3,600 shares on March 14, 2027; 4,500 shares on March 14, 2028 and 5,400 shares on March 14, 2029.

9. The options vest in four equal installments on March 14, 2026, March 14, 2027, March 14, 2028 and March 14, 2029.

10. The restricted stock units were granted under the Monster Beverage Corporation 2020 Omnibus Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of the Company's common stock as of the vesting date.

11. The remaining restricted stock units vest on March 12, 2026.

12. Not applicable.

13. The remaining restricted stock units vest in two installments as follows: 3,400 units on March 14, 2026 and 4,080 units on March 14, 2027.

14. The remaining restricted stock units vest in three installments as follows: 1,360 units on March 14, 2026; 1,700 units on March 14, 2027 and 2,040 units on March 14, 2028.

15. The remaining restricted stock units vest in four installments as follows: 900 units on March 14, 2026; 1,200 units on March 14, 2027; 1,500 units on March 14, 2028 and 1,800 units on March 14, 2029.

16. The restricted stock units vest in four equal installments on March 14, 2026, March 14, 2027, March 14, 2028 and March 14, 2029.

	Paul J. Dechary, attorney-in-fact	11/17/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider activity did MNST report on Form 4 for 11/13/2025?

The Form 4 shows a Monster Beverage officer exercised multiple employee stock options on 11/13/2025 and sold 38,438 shares of common stock the same day.

How many Monster Beverage (MNST) shares did the insider sell and at what price?

The insider sold 38,438 Monster Beverage shares at a weighted average sale price of $71.33, with individual trades executed between $70.09 and $71.70.

How many MNST shares did the insider own after the reported transactions?

Following the reported option exercises and share sale, the officer beneficially owned 21,993 shares of Monster Beverage common stock directly.

What stock options did the Monster Beverage insider exercise on 11/13/2025?

The officer exercised employee stock options with exercise prices of $25.75, $44.47, $36.62 and $50.82, acquiring share lots such as 9,000, 16,100 and 13,332 MNST shares.

What equity awards remain outstanding for the MNST officer after these transactions?

The filing lists remaining employee stock options and restricted stock units tied to Monster Beverage common stock, with various tranches vesting on dates including March 12, 2026 and March 14 in years through 2029.

Under which plan were the Monster Beverage restricted stock units granted?

The restricted stock units were granted under the Monster Beverage Corporation 2020 Omnibus Incentive Plan, with each unit representing one share upon vesting.

Who signed the MNST Form 4 filing on behalf of the reporting person?

The Form 4 was signed by Paul J. Dechary as attorney-in-fact for the reporting person on 11/17/2025.